---
document_datetime: 2024-08-16 14:43:25
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/insulin-lispro-sanofi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: insulin-lispro-sanofi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.8776225
conversion_datetime: 2025-12-30 07:47:41.24999
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Insulin lispro Sanofi

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0019               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 14/08/2024                          |                                             | PL                               |           |
| IA/0018/G            | This was an application for a group of variations.                                               | 20/12/2023                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | and/or limits of the immediate packaging of the AS - Tightening of specification limits B.I.c.2.b - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition of a new specification parameter to the specification with its corresponding test method B.I.c.2.c - Change in the specification parameters and/or limits of the immediate packaging of the AS - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.I.c.3.a - Change in test procedure for the immediate packaging of the AS - Minor changes to an approved test procedure   |            |            |                        |                                                                                                                                                                                                                                                                                     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0017    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 06/07/2023 |            | PL                     |                                                                                                                                                                                                                                                                                     |
| T/0016    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 15/11/2022 | 09/12/2022 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                                     |
| R/0013    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 27/01/2022 | 28/03/2022 | SmPC, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Insulin lispro Sanofi in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| II/0014/G | This was an application for a group of variations. B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                                                                                                               | 13/01/2022 | n/a        |                        |                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|                    | B.II.b.3.b - Change in the manufacturing process of the finished or intermediate product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product                                  |            |            |                       |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-----------------------------------|
| PSUSA/1755/ 202104 | Periodic Safety Update EU Single assessment - insulin lispro                                                                                                                                                                                                               | 02/12/2021 | n/a        |                       | PRAC Recommendation - maintenance |
| N/0015             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                           | 26/11/2021 | 28/03/2022 | PL                    |                                   |
| PSUSA/1755/ 202004 | Periodic Safety Update EU Single assessment - insulin lispro                                                                                                                                                                                                               | 26/11/2020 | n/a        |                       | PRAC Recommendation - maintenance |
| N/0011             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                           | 23/10/2020 | 28/07/2021 | PL                    |                                   |
| IG/1282            | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                         | 15/09/2020 | n/a        |                       |                                   |
| IAIN/0008          | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                             | 10/08/2020 | 28/07/2021 | SmPC, Annex II and PL |                                   |
| IB/0007/G          | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process | 08/04/2020 | n/a        |                       |                                   |

<div style=\"page-break-after: always\"></div>

|           | of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |    |                      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|----------------------|
| N/0006    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 20/02/2020 | 28/07/2021 | PL |                      |
| N/0005    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 13/05/2019 | 29/10/2019 | PL |                      |
| IG/0999/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient change - Change in the name | 20/11/2018 | n/a        |    | A.4 - Administrative |

<div style=\"page-break-after: always\"></div>

|           | starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   |            |            |                     | or supplier of the AS,   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------|--------------------------|
| IB/0003/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                  | 26/10/2018 | 29/10/2019 | SmPC and PL         |                          |
| IB/0002   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 03/04/2018 | 02/08/2018 | SmPC, Labelling and |                          |

<div style=\"page-break-after: always\"></div>

|             |                                                                      |            |            | PL                     |                                                                                                   |
|-------------|----------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------|
| IAIN/0001/G | This was an application for a group of variations. or administration | 29/08/2017 | 02/08/2018 | SmPC, Labelling and PL | B.IV.1.a.1 - Change of a measuring device - Addition or replacement not an integrated part of the |